| GLP-1 receptor agonists among patients with overweight or obesity, diabetes, and HFpEF on SGLT2 inhibitors R Patel, M Wadid, B Makwana, A Kumar, S Khadke, A Bhatti, A Banker, ... JACC: Heart Failure, 2024 | 1 | 2024 |
| Assessing the impact of atrial fibrillation on symptoms and quality of life in hypertrophic cardiomyopathy EJ Rowin, M Wadid, MS Maron, M White, BG Hook, P Harnish, JS Silver, ... Journal of Cardiovascular Electrophysiology 35 (4), 654-663, 2024 | 1 | 2024 |
| PO-02-157 IMPACT OF ATRIAL FIBRILLATION ON QUALITY OF LIFE IN HYPERTROPHIC CARDIOMYOPATHY M Wadid, M White, JS Silver, BG Hook, BJ Maron, M Maron, E Rowin Heart Rhythm 20 (5), S292, 2023 | 1 | 2023 |
| “NAVIGATING STORMY WATERS”: UNVEILING COMPLICATIONS OF CATHETER-DIRECTED THROMBOLYSIS FOR THE MANAGEMENT OF INTERMEDIATE-HIGH RISK PULMONARY EMBOLISMS M Wadid, M Bello Journal of the American College of Cardiology 83 (13_Supplement), 4139-4139, 2024 | | 2024 |
| DIABETIC KETOACIDOSIS TRENDS IN HEART FAILURE PATIENTS ON ANTIHYPERGLYCEMIC AGENTS: INSIGHTS POST-SGLT2 INHIBITOR INTEGRATION INTO GUIDELINE-DIRECTED MEDICAL THERAPY T Drago, M Wadid, P Brodeur, L Palatnic, US Najam, R Bharucha, ... Journal of the American College of Cardiology 83 (13_Supplement), 495-495, 2024 | | 2024 |
| Variations in Atrial Fibrillation Ablation Use and Charges in a Modern Cohort of Medicare Beneficiaries A Aglan, AR Fath, A Khurana, J Aboasbeh, AS Eldaly, M Wadid, ... The American Journal of Cardiology 202, 24-29, 2023 | | 2023 |
| Trends in Diabetic Ketoacidosis Among Heart Failure Patients Using Antihyperglycemic Agents: Observations Following the Inclusion of SGLT2 Inhibitors in Guideline-Directed … T Drago, M Wadid, P Brodeur, L Palatnic, U Najam, R Bharucha, R Moyer, ... | | |
| The Importance of Interprofessional Collaboration in the Intensive Care Unit JL Jeger, M Wadid | | |
